Feasibility and outcome of patients with medulloblastoma treated with pre-irradiation chemotherapy and reduced dose craniospinal radiotherapy (csrh) using mycc as a molecular marker for prognosis

Journal article

Peer reviewed

W. H. Elsawy, M. Abdel Kader, W. E. Hamoda, Y. Dorgham, M. Abdullah, S. Eltarhony and A. F. Gharib

Journal of clinical oncology, Vol.26(15_suppl), pp.10040-10040

20/05/2008

Abstract

Abstract only

1 Record Views

Title: Feasibility and outcome of patients with medulloblastoma treated with pre-irradiation chemotherapy and reduced dose craniospinal radiotherapy (csrh) using mycc as a molecular marker for prognosis
Creators - without role: W. H. Elsawy
M. Abdel Kader
W. E. Hamoda
Y. Dorgham
M. Abdullah
S. Eltarhony
A. F. Gharib
Publication Details: Journal of clinical oncology, Vol.26(15_suppl), pp.10040-10040
Identifiers: 9910997008331
Academic Unit: Taif University
Language: English
Resource Type: Journal article